EVOTEC SE (EVT.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:EVT - DE0005664809 - Common Stock
5.8 EUR
-0.01 (-0.24%)
We assign a fundamental rating of 3 out of 10 to EVT. EVT was compared to 19 industry peers in the Life Sciences Tools & Services industry. EVT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. EVT has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year EVT has reported negative net income.
In the past year EVT had a positive cash flow from operations.
In multiple years EVT reported negative net income over the last 5 years.
EVT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
EVT has a Return On Assets of -8.97%. This is amonst the worse of the industry: EVT underperforms 94.74% of its industry peers.
With a Return On Equity value of -19.87%, EVT is not doing good in the industry: 89.47% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.97% | ||
| ROE | -19.87% | ||
| ROIC | N/A |
ROA(3y)-7.25%
ROA(5y)-2.34%
ROE(3y)-14.29%
ROE(5y)-5.27%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
EVT's Gross Margin of 10.82% is on the low side compared to the rest of the industry. EVT is outperformed by 94.74% of its industry peers.
In the last couple of years the Gross Margin of EVT has declined.
The Profit Margin and Operating Margin are not available for EVT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 10.82% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.23%
GM growth 5Y-13.5%
2. Health
2.1 Basic Checks
EVT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EVT has more shares outstanding
EVT has more shares outstanding than it did 5 years ago.
EVT has a better debt/assets ratio than last year.
2.2 Solvency
EVT has an Altman-Z score of 1.17. This is a bad value and indicates that EVT is not financially healthy and even has some risk of bankruptcy.
EVT has a worse Altman-Z score (1.17) than 73.68% of its industry peers.
A Debt/Equity ratio of 0.48 indicates that EVT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.48, EVT is in the better half of the industry, outperforming 68.42% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.17 |
ROIC/WACCN/A
WACC7.33%
2.3 Liquidity
A Current Ratio of 2.12 indicates that EVT has no problem at all paying its short term obligations.
EVT has a better Current ratio (2.12) than 94.74% of its industry peers.
EVT has a Quick Ratio of 2.03. This indicates that EVT is financially healthy and has no problem in meeting its short term obligations.
EVT's Quick ratio of 2.03 is amongst the best of the industry. EVT outperforms 94.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.12 | ||
| Quick Ratio | 2.03 |
3. Growth
3.1 Past
EVT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -136.17%.
EVT shows a decrease in Revenue. In the last year, the revenue decreased by -2.67%.
The Revenue has been growing by 12.29% on average over the past years. This is quite good.
EPS 1Y (TTM)-136.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.09%
Revenue 1Y (TTM)-2.67%
Revenue growth 3Y8.85%
Revenue growth 5Y12.29%
Sales Q2Q%-11.36%
3.2 Future
Based on estimates for the next years, EVT will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.47% on average per year.
EVT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.09% yearly.
EPS Next Y59.73%
EPS Next 2Y35.6%
EPS Next 3Y28%
EPS Next 5Y18.47%
Revenue Next Year-2.27%
Revenue Next 2Y4.05%
Revenue Next 3Y6.5%
Revenue Next 5Y5.09%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for EVT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EVT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, EVT is valued more expensive than 94.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 1208.16 |
4.3 Compensation for Growth
EVT's earnings are expected to grow with 28.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.6%
EPS Next 3Y28%
5. Dividend
5.1 Amount
EVT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:EVT (11/28/2025, 7:00:00 PM)
5.8
-0.01 (-0.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners60.42%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.06B
Revenue(TTM)756.33M
Net Income(TTM)-158.98M
Analysts78.46
Price Target9.23 (59.14%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-64.24%
Min EPS beat(2)-106.63%
Max EPS beat(2)-21.86%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.97%
Min Revenue beat(2)-9.17%
Max Revenue beat(2)-4.77%
Revenue beat(4)0
Avg Revenue beat(4)-4.99%
Min Revenue beat(4)-9.17%
Max Revenue beat(4)-0.93%
Revenue beat(8)1
Avg Revenue beat(8)-3.74%
Revenue beat(12)4
Avg Revenue beat(12)1.12%
Revenue beat(16)7
Avg Revenue beat(16)2.95%
PT rev (1m)-2.29%
PT rev (3m)-3.03%
EPS NQ rev (1m)137.5%
EPS NQ rev (3m)733.33%
EPS NY rev (1m)5.49%
EPS NY rev (3m)5.08%
Revenue NQ rev (1m)4.39%
Revenue NQ rev (3m)6.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.72 | ||
| P/FCF | N/A | ||
| P/OCF | 1460.72 | ||
| P/B | 2.57 | ||
| P/tB | 4.12 | ||
| EV/EBITDA | 1208.16 |
EPS(TTM)-1.11
EYN/A
EPS(NY)-0.18
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)0
OCFY0.07%
SpS2.13
BVpS2.25
TBVpS1.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.97% | ||
| ROE | -19.87% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 10.82% | ||
| FCFM | N/A |
ROA(3y)-7.25%
ROA(5y)-2.34%
ROE(3y)-14.29%
ROE(5y)-5.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.23%
GM growth 5Y-13.5%
F-Score4
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 209.82 | ||
| Cap/Depr | 90.72% | ||
| Cap/Sales | 12.19% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 76.3% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.12 | ||
| Quick Ratio | 2.03 | ||
| Altman-Z | 1.17 |
F-Score4
WACC7.33%
ROIC/WACCN/A
Cap/Depr(3y)186.39%
Cap/Depr(5y)182.37%
Cap/Sales(3y)22.79%
Cap/Sales(5y)21.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-136.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-9.09%
EPS Next Y59.73%
EPS Next 2Y35.6%
EPS Next 3Y28%
EPS Next 5Y18.47%
Revenue 1Y (TTM)-2.67%
Revenue growth 3Y8.85%
Revenue growth 5Y12.29%
Sales Q2Q%-11.36%
Revenue Next Year-2.27%
Revenue Next 2Y4.05%
Revenue Next 3Y6.5%
Revenue Next 5Y5.09%
EBIT growth 1Y-6.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year132.47%
EBIT Next 3Y50.57%
EBIT Next 5Y33.1%
FCF growth 1Y52.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y107.69%
OCF growth 3Y-46.98%
OCF growth 5Y-15.47%
EVOTEC SE / EVT.DE FAQ
Can you provide the ChartMill fundamental rating for EVOTEC SE?
ChartMill assigns a fundamental rating of 3 / 10 to EVT.DE.
Can you provide the valuation status for EVOTEC SE?
ChartMill assigns a valuation rating of 1 / 10 to EVOTEC SE (EVT.DE). This can be considered as Overvalued.
How profitable is EVOTEC SE (EVT.DE) stock?
EVOTEC SE (EVT.DE) has a profitability rating of 1 / 10.
How financially healthy is EVOTEC SE?
The financial health rating of EVOTEC SE (EVT.DE) is 5 / 10.